Abstract updates
Play an active role at EASL Congress 2023.
Get ready to share your research and present it on stage.
Play an active role at EASL Congress 2023.
Share your research on stage or as a poster.
Play an active role at EASL Congress 2023.
Get ready to share your research and present it on stage.
The late breaker abstract submission will open on 12 April. Stay tuned for updates.
For those who had their abstract accepted, we are pleased to announce that the guidelines for abstract presentation are now available. Please make sure to consult them carefully to ensure a successful presentation.
We look forward to seeing you at the EASL Congress 2023!
The abstract submission for EASL Congress 2023 has now closed. We received an overwhelming response with over 2350 abstracts submitted from 80 countries.
We appreciate your interest and enthusiasm for the Congress. Our panel of experts is currently reviewing the submissions, and we will notify the abstract submitters on April 11.
Thank you for your participation and contribution to EASL Congress 2023. We look forward to seeing you in Vienna.
We are expecting more than 2,500 abstracts. Accepted ones will be selected to be presented either at an oral abstract session or as a poster. A selection of posters will be part of poster tours, where a member of the faculty will be present to lead the discussion around them.
We are expecting more than 2,500 abstracts. Accepted ones will be selected to be presented either at an oral abstract session or as a poster.
A selection of posters will be part of poster tours, where a member of the faculty will be present to lead the discussion around them.
The late-breaker abstract submission will open on 12 April. You can submit your abstracts until the 26 April. Don't miss the chance to share your latest findings and insights with the liver community. Check out the late-breaker guidelines below.
For those who had their abstract accepted, we are pleased to announce that the guidelines for abstract presentation are now available. Please make sure to consult them carefully to ensure a successful presentation.
We look forward to seeing you at the EASL Congress 2023!
Discover the EASL Congress 2023 Abstract book
We invite you to have a look at the Abstract Book of the EASL Congress 2023.
This will give you a better understanding of the new research that will be shared at the congress!
Click to read the guidelines
Discover the list of all the accepted abstracts!
We invite you to have a look at the list of accepted abstracts for the EASL Congress 2023 before joining us. You can find the full list at the link below.
This will give you a better understanding of the new research that will be shared at the congress!
Key deadlines
Key deadlines
Abstract notification:
11 April 2023
Late-breakers open
12 April 2023
Late-breakers close
26 April 2023
Top reasons to submit an abstract
- All accepted abstracts will be published in the yearly supplement of the leading high-impact Journal of Hepatology (JHEP)
- All presentations (oral or poster) will be available on-demand on EASL Campus
- Share your research to get more exposure
- Boost your career and create a network with people working in your field
- Present your work to peers and expert leaders and raise your visibility
- Top Trainee & Postdoc abstracts will qualify for an abstract award (8 in posters and 2 orals) – 500 EUR for posters and 1,000 EUR for oral)
- All accepted abstracts will be published in the yearly supplement of the leading high-impact Journal of Hepatology (JHEP)
- All presentations (oral or poster) will be available on-demand on EASL Campus
- Share your research to get more exposure
- Boost your career and create a network with people working in your field
- Present your work to peers and expert leaders and raise your visibility
- Top Trainee & Postdoc abstracts will qualify for an abstract award (8 in posters and 2 orals) – 500 EUR for posters and 1,000 EUR for oral)
Any questions on abstracts/late-breakers/presentations?
Unsure about which category to submit your abstract?
Click to jump to any of the following sections:
You will be able to discover abstracts in these major tracks at EASL Congress 2023:
The Scientific Committee is looking forward to receiving your abstract in these major tracks:
You will be able to discover abstracts in these major tracks at EASL Congress 2023:
Do you want to present your research at EASL Congress 2023?
If you are doing research around the liver in Clinical Science, Basic & Translational Science or Public Health, or if you are a nurse or Allied Health Professional, then we want you to contribute.
Do you want to present your research at EASL Congress 2023?
If you are doing research around the liver in Clinical Science, Basic & Translational Science or Public Health, or if you are a nurse or Allied Health Professional, then we want you to contribute.
Abstract categories
Each of the four topics below lists specific categories, find the one that best matches your research, to make sure it will get reviewed by the most prominent experts in the field.
Each of the four topics below lists specific categories, find the one that best matches your research, to make sure it will get reviewed by the most prominent experts in the field.
| Acute liver failure and drug induced liver injury |
| Alcohol-related liver disease |
| Cirrhosis and its complications: ACLF and Critical illness |
| Cirrhosis and its complications: Other clinical complications except ACLF and critical illness |
| Cirrhosis and its complications: Portal Hypertension |
| Immune-mediated and cholestatic disease: Clinical aspects |
| Liver transplantation and hepatobiliary surgery |
| Liver tumours: Clinical aspects except therapy |
| Liver tumours: Therapy |
| NAFLD: Clinical aspects except therapy |
| NAFLD: Diagnostics and non-invasive assessment |
| NAFLD: Therapy |
| Non-invasive assessment of liver disease except NAFLD |
| Rare liver diseases (including paediatric and genetic) |
| Viral hepatitis A/E: Clinical aspects |
| Viral hepatitis B and D: Clinical aspects |
| Viral Hepatitis B and D: Current therapies |
| Viral Hepatitis B and D: New therapies, unapproved therapies or strategies |
| Viral Hepatitis C: Clinical aspects including follow up after SVR |
| Viral hepatitis C: Therapy and resistance |
| Acute liver failure and drug induced liver injury |
| Alcohol-related liver disease |
| Cirrhosis and its complications: Experimental and pathophysiology |
| Fibrosis / Stellate cell biology |
| Gut microbiota and liver disease / Liver-organ crosstalk |
| Hepatocyte biology |
| Immune-mediated and cholestatic: Experimental and pathophysiology |
| Liver development and regeneration |
| Liver immunology |
| Liver transplantation and hepatobiliary surgery |
| Liver tumours: Experimental and pathophysiology |
| NAFLD: Experimental and pathophysiology |
| Rare liver diseases (including paediatric and genetic) |
| Viral Hepatitis: Experimental and pathophysiology |
| Nurses and Allied Health Professionals |
| Public Health: Except viral hepatitis |
| Public Health: Viral hepatitis |
Any questions on abstracts?
Unsure about which category to submit your abstract?
| Acute liver failure and drug induced liver injury |
| Alcohol-related liver disease |
| Cirrhosis and its complications: ACLF and Critical illness |
| Cirrhosis and its complications: Other clinical complications except ACLF and critical illness |
| Cirrhosis and its complications: Portal Hypertension |
| Immune-mediated and cholestatic disease: Clinical aspects |
| Liver transplantation and hepatobiliary surgery |
| Liver tumours: Clinical aspects except therapy |
| Liver tumours: Therapy |
| NAFLD: Clinical aspects except therapy |
| NAFLD: Diagnostics and non-invasive assessment |
| NAFLD: Therapy |
| Non-invasive assessment of liver disease except NAFLD |
| Rare liver diseases (including paediatric and genetic) |
| Viral hepatitis A/E: Clinical aspects |
| Viral hepatitis B and D: Clinical aspects |
| Viral Hepatitis B and D: Current therapies |
| Viral Hepatitis B and D: New therapies, unapproved therapies or strategies |
| Viral Hepatitis C: Clinical aspects including follow up after SVR |
| Viral hepatitis C: Therapy and resistance |
| Acute liver failure and drug induced liver injury |
| Alcohol-related liver disease |
| Cirrhosis and its complications: Experimental and pathophysiology |
| Fibrosis / Stellate cell biology |
| Gut microbiota and liver disease / Liver-organ crosstalk |
| Hepatocyte biology |
| Immune-mediated and cholestatic: Experimental and pathophysiology |
| Liver development and regeneration |
| Liver immunology |
| Liver transplantation and hepatobiliary surgery |
| Liver tumours: Experimental and pathophysiology |
| NAFLD: Experimental and pathophysiology |
| Rare liver diseases (including paediatric and genetic) |
| Viral Hepatitis: Experimental and pathophysiology |
| Nurses and Allied Health Professionals |
| Public Health: Except viral hepatitis |
| Public Health: Viral hepatitis |
Any questions on abstracts?
Abstract notification:
11 April 2023
Late-breakers open
12 April 2023
Late-breakers close
26 April 2023
Abstract submission fee: 50 EUR (excl. VAT)
Abstract submitters from Ukraine and low-income economies* will be exempted from the EUR 50 required to submit their abstract(s). If you are from one of these countries, you can submit your abstract cost-free.
Abstract submission fee: 50 EUR
(excl. VAT)
Abstract submitters from Ukraine and low-income economies* will be exempted from the EUR 50 required to submit their abstract(s). If you are from one of these countries, you can submit your abstract cost-free.
EASL supports you!
EASL offers 400 bursaries for Trainees and Postdocs, Nurses and Allied Health Professionals (AHPs) whose abstracts are accepted.
*As per the World Bank classification Low-income economies refers to this listing of 29 countries:
Afghanistan, Burkina Faso, Burundi, Central African Republic, Chad, Congo Dem. Rep, Eritrea, Ethiopia, Gambia The, Guinea, Guinea-Bissau, Korea Dem., People’s Rep., Liberia, Madagascar, Malawi, Mali, Mozambique, Niger, Rwanda, Sierra Leone, Somalia, South Sudan, Sudan, Syrian Arab Republic, Tajikistan, Togo, Uganda, Yemen Rep, Zambia.
EASL supports you!
EASL offers 400 bursaries for Trainees and Postdocs, Nurses and Allied Health Professionals (AHPs) whose abstracts are accepted.
How to submit your abstract
Here is everything you need to know about making your mark and submitting your abstract for EASL Congress 2023.
Here is everything you need to know about making your mark and submitting your abstract for EASL Congress 2023.
Solve the case
Do you have a case of a patient that worries you and/or you are not sure how to solve it?
Do you have doubts on the diagnosis, on therapy or on general management?
Would you like to discuss it and take advice from major experts in the field? Now you can! Bring it to the “Hepatology Arena”, at the interactive sessions “Solve the Case”.
EASL will offer free registration to the presenters of selected cases!
Solve the case
Do you have a case of a patient that worries you and/or you are not sure how to solve it?
Do you have doubts on the diagnosis, on therapy or on general management?
Would you like to discuss it and take advice from major experts in the field? Now you can! Bring it to the “Hepatology Arena”, at the interactive sessions “Solve the Case”.
EASL will offer free registration to the presenters of selected cases!
